- JP-listed companies
- Other
【JP:4597】Other
Market cap
¥7B
P/E ratio
Develops and commercializes innovative cancer medicines across Asian markets including Japan, China, and South Korea, focusing on treatments and supportive care.
| 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | -28.7 | -42.4 | -42.8 | -2.5 | -31.9 | -8.2 | -15.9 | -12.8 | -59.6 | -51.1 |
| Return on equity (%) | - | - | - | - | ||||||||||
| Employees | 7 | 12 | 16 | 16 | 16 | 21 | 31 | 52 | 77 | 77 | 27 | 24 | 23 | - |